Condition: Squamous Cell Carcinoma of Oropharynx · HPV Positive Cancer · Throat Cancer · Sponsor: Indiana University
This study is a prospective phase II trial, designed to assess the efficacy and feasibility of adjuvant treatment deintensification guided by ctHPVDNA levels for patients with HPV+OPSCC who undergo transoral surgery and neck dissection.
This description comes directly from the study's public registry record.
Azeezat Yekinni · 317-529-6883 · ayekinn@iu.edu
Always discuss trial participation with your own doctor first.
| IU Health Joe and Shelly Schwarz Cancer Center | Carmel, Indiana, United States | Recruiting |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915038